The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Tumor progression and metastasis
Abstract
It is now widely accepted that cancer is attributed to the accumulation of genetic alterations in cells. Thus, to understand the molecular mechanisms of cancer metastasis, it is indispensable to identify the genes whose alterations accumulate during cancer progression as well as the genes whose expression is responsible for the acquisition of metastatic potential in cancer cells. Molecular analyses of cancer cells in various stages of progression have revealed that alterations in tumor suppressor genes and oncogenes accumulate during tumor progression and correlate with the clinical aggressiveness of cancer. Comparative analyses of gene expression profiles between metastatic and non-metastatic cells have revealed that various genes are differentially expressed in association with the metastatic potential of cancer cells. A number of genes have been also identified as having functions in inducing or suppressing metastasis in experimental models. However, the association between causative genetic alterations and resulting phenotypic alterations with respect to the metastatic potential of cancer cells is not fully understood. Therefore, elucidation of genotype-phenotype correlation will be required to further understand a complex process of metastasis. Here, I review the progress on molecular studies of tumor progression and metastasis of the past 20 years and discuss the future direction in this field of science.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Differential Display of Eukaryotic Messenger RNA by Means of the Polymerase Chain Reaction
Liang, P., & Pardee, A. B. (1992) · Science · doi:10.1126/science.1354393 · Cited by 4,984
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Signer, S. H., Davidson, N., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,733
Ionov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D., & Perucho, M. (1993) · Nature · doi:10.1038/363558a0 · Cited by 2,708
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,270
Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease Stage
Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E., & Bishop, J. M. (1984) · Science · doi:10.1126/science.6719137 · Cited by 2,262
Association of Multiple Copies of the N-myc Oncogene with Rapid Progression of Neuroblastomas
Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K. Y., & Hammond, D. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510313131802 · Cited by 2,010
Expression of recessive alleles by chromosomal mechanisms in retinoblastoma
Cavenee, W. K., Dryja, T. P., Phillips, R. A., Benedict, W. F., Godbout, R., Gallie, B. L., Murphree, A. L., Strong, L. C., & White, R. L. (1983) · Nature · doi:10.1038/305779a0 · Cited by 1,920
Expression profiling using cDNA microarrays
Duggan, D. J., Bittner, M., Chen, Y., Meltzer, P., & Trent, J. M. (1999) · Nature Genetics · doi:10.1038/4434 · Cited by 1,657
Molecular themes in oncogenesis
Bishop, J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90636-d · Cited by 1,637
Selection of Successive Tumour Lines for Metastasis
FIDLER, I. J. (1973) · Nature New Biology · doi:10.1038/newbio242148a0 · Cited by 1,361
Herman, J. G., Merlo, A. U., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D., & Baylin, S. B. (1995) · PubMed · Cited by 1,341
Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J. C., & Perucho, M. (1997) · Science · doi:10.1126/science.275.5302.967 · Cited by 1,326
Hereditary cancer, oncogenes, and antioncogenes.
Knudson, A. G. (1985) · PubMed · Cited by 1,218
Fidler, I. J. (1990) · PubMed · Cited by 1,139
Cellular Oncogenes and Multistep Carcinogenesis
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Science · doi:10.1126/science.6356358 · Cited by 1,127
Essential role for oncogenic Ras in tumour maintenance
Chin, L., Tam, A., Pomerantz, J., Wong, M., Holash, J., Bardeesy, N., Shen, Q., O'Hagan, R., Pantginis, J., Zhou, H., et al. (1999) · Nature · doi:10.1038/22788 · Cited by 875
KAI1 , a Metastasis Suppressor Gene for Prostate Cancer on Human Chromosome 11p11.2
Dong, J.-T., Lamb, P. W., Rinker-Schaeffer, C. W., Vukanovic, J., Ichikawa, T., Isaacs, J. T., & Barrett, J. C. (1995) · Science · doi:10.1126/science.7754374 · Cited by 757
Allelic Loss of Chromosome 18q and Prognosis in Colorectal Cancer
Jen, J., Kim, H., Piantadosi, S., Liu, Z.-F., Levitt, R. C., Sistonen, P., Kinzler, K. W., Vogelstein, B., & Hamilton, S. R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407283310401 · Cited by 696
Human Cancer Syndromes: Clues to the Origin and Nature of Cancer
Fearon, E. R. (1997) · Science · doi:10.1126/science.278.5340.1043 · Cited by 605
Lander, E. S. (1999) · Nature Genetics · doi:10.1038/4427 · Cited by 554
Habets, G. G. M., Scholtes, E. H. M., Zuydgeest, D., van der Kammen, R. A., Stam, J. C., Berns, A., & Collard, J. G. (1994) · Cell · doi:10.1016/0092-8674(94)90216-x · Cited by 510
Nicolson, G. L. (1987) · PubMed · Cited by 502
Yokota, J., Wada, M., Shimosato, Y., Terada, M., & Sugimura, T. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9252 · Cited by 480
Self-citationp53: At the Crossroads of Molecular Carcinogenesis and Risk Sssessment
Harris, C. C. (1993) · Science · doi:10.1126/science.8266092 · Cited by 475
Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells
Klein, C. A., Schmidt-Kittler, O., Schardt, J. A., Pantel, K., Speicher, M. R., & Riethmüller, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4494 · Cited by 450
Nucleic Acid-Based Methods for the Detection of Cancer
Sidransky, D. (1997) · Science · doi:10.1126/science.278.5340.1054 · Cited by 405
Yokota, J., Tsunetsugu-Yokota, Y., Battifora, H., Le Fevre, C., & Cline, M. J. (1986) · Science · doi:10.1126/science.3941898 · Cited by 374
Self-citationLee, J., & Welch, D. R. (1997) · PubMed · Cited by 371
Clinical significance of ras oncogene activation in human lung cancer
(1993) · Lung Cancer · doi:10.1016/0169-5002(93)90536-7 · Cited by 360
Toh, Y., Pencil, S. D., & Nicolson, G. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31603-4 · Cited by 350
(1995) · Lung Cancer · doi:10.1016/0169-5002(95)98734-r · Cited by 312
Van Meir, E. G., Polverini, P. J., Chazin, V. R., Su Huang, H.-J., de Tribolet, N., & Cavenee, W. K. (1994) · Nature Genetics · doi:10.1038/ng1094-171 · Cited by 307
Nishimori, H., Shiratsuchi, T., Urano, T., Kimura, Y., Kiyono, K., Tatsumi, K., Yoshida, S., Ono, M., Kuwano, M., Nakamura, Y., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201542 · Cited by 293
Progress in understanding the molecular pathogenesis of human lung cancer
Sekido, Y., Fong, K. M., & Minna, J. D. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00010-9 · Cited by 290
p300 gene alterations in colorectal and gastric carcinomas.
Muraoka, M., Konishi, M., Kikuchi‐Yanoshita, R., Tanaka, K., Shitara, N., Chong, J., Iwama∥, T., & Miyaki, M. (1996) · PubMed · Cited by 282
Ponder, B. (1988) · Nature · doi:10.1038/335400a0 · Cited by 277
Davies, B. R., Davies, M. P. A., Gibbs, F. E. M., Barraclough, R., & Rudland, P. S. (1993) · PubMed · Cited by 251
Bouvet, M., Ellis, L. M., Nishizaki, M., Fujiwara, T., Liu, W., Bucana, C. D., Fang, B., Lee, J. J., & Roth, J. A. (1998) · PubMed · Cited by 242
Cancer of the microsatellite mutator phenotype.
Perucho, M. (1996) · PubMed · Cited by 227
Establishing a Link between Oncogenes and Tumor Angiogenesis
Kerbel, R. S., Viloria‐Petit, A., Okada, F., & Rak, J. W. (1998) · Molecular Medicine · doi:10.1007/bf03401737 · Cited by 168
E-cadherin downregulation in cancer: fuel on the fire?
Guilford, P. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01461-6 · Cited by 168
Expressed sequence tags — ESTablishing bridges between genomes
Marra, M. A., Hillier, L., & Waterston, R. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(97)01355-3 · Cited by 148
Tumour-suppressor genes: evolving definitions in the genomic age
Haber, D. A., & Harlow, E. (1997) · Nature Genetics · doi:10.1038/ng0897-320 · Cited by 141
Hashimoto, Y., Shindo‐Okada, N., Tani, M., Nagamachi, Y., Takeuchi, K., Shiroishi, T., Toma, H., & Yokota, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.3.289 · Cited by 135
Self-citationOokawa, K., Sakamoto, M., Hirohashi, S., Yoshida, Y., Sügimura, T., Terada, M., & Yokota, J. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530307 · Cited by 134
Self-citationFrequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma.
Shiseki, M., Kohno, T., Nishikawa, R., Sameshima, Y., Mizoguchi, H., & Yokota, J. (1994) · PubMed · Cited by 133
Self-citationMultiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes
Yokota, J., & Sügimura, T. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.10.8344488 · Cited by 130
Self-citationExpression of the metastatic phenotype in cells transfected with human metastatic tumor DNA.
Bernstein, S. C., & Weinberg, R. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.6.1726 · Cited by 108
How many tumor suppressor genes are involved in human lung carcinogenesis?
Kohno, T. (1999) · Carcinogenesis · doi:10.1093/carcin/20.8.1403 · Cited by 105
Yokota, J., Wada, M., Yoshida, T., Noguchi, M., Terasaki, T., Shimosato, Y., Sugimura, T., & Terada, M. (1989) · Lung Cancer · doi:10.1016/0169-5002(89)90332-2 · Cited by 82
Self-citationGenetic changes in epithelial solid neoplasia.
Rodrı́guez, E., Sreekantaiah, C., & Chaganti, R. S. K. (1994) · PubMed · Cited by 81
Kelley, M. J., Nakagawa, K., Steinberg, S., Mulshine, J. L., Kamb, A., & Johnson, B. E. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.10.756 · Cited by 80
Malkhosyan, S. R., Yasuda, J., Soto, J. L., Sekiya, T., Yokota, J., & Perucho, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10170 · Cited by 53
Self-citationToward a Complete Human Genome SequencePreprint
The Sanger Centre, & The Washington University Genome Sequencing Center (1998) · Genome Research · doi:10.1101/gr.8.11.1097 · Cited by 49
Cited by
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy
Lin, E. Y., Nguyen, A. V., Russell, R. G., & Pollard, J. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.727 · Cited by 1,594
On the Origin of Cancer Metastasis
Seyfried, T. N., & Huysentruyt, L. C. (2013) · Critical Reviews in Oncogenesis · doi:10.1615/critrevoncog.v18.i1-2.40 · Cited by 1,196
Seyfried, T. N., & Shelton, L. M. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-7 · Cited by 644
Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer
Vallières, M., Kay-Rivest, E., Perrin, L. J., Liem, X., Furstoss, C., Aerts, H. J. W. L., Khaouam, N., Nguyen-Tan, P. F., Wang, C.-S., Sultanem, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10371-5 · Cited by 542
Metadata
- Authors
- Yokota, J.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-03
- Volume
- 21
- Issue
- 3
- Pages
- 497-503
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2097705418
- Cited by
- 426
- References
- 65
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.